UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Chimeric Antigen Receptor T‐Cell Therapy Clinical Results in Pediatric and Young Adult B‐ALL

HemaSphere, 2019-08, Vol.3 (4), p.e279-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States

PloS one, 2016-03, Vol.11 (3), p.e0151362-e0151362

2016

Link zum Volltext

Verfügbarkeit prüfen

Will allogeneic CAR T cells for CD19 + malignancies take autologous CAR T cells 'off the shelf'?

Nature reviews. Clinical oncology, 2021-04, Vol.18 (4), p.195-196

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial

Journal of clinical oncology, 2021-03, Vol.39 (8), p.920-930

2021

Link zum Volltext

Verfügbarkeit prüfen

Tisagenlecleucel for treatment of children and young adults with relapsed/refractory B‐cell acute lymphoblastic leukemia

Pediatric blood & cancer, 2021-09, Vol.68 (9), p.e29123-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Subcutaneous immunoglobulin replacement following CD19‐specific chimeric antigen receptor T‐cell therapy for B‐cell acute lymphoblastic leukemia in pediatric patients

Pediatric blood & cancer, 2020-03, Vol.67 (3), p.e28092-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Analysis of semen parameters in a young cohort of cancer patients

Pediatric blood & cancer, 2017-02, Vol.64 (2), p.381-386

2017

Link zum Volltext

Verfügbarkeit prüfen

Identifying relapses and stem cell transplants in pediatric acute lymphoblastic leukemia using administrative data: Capturing national outcomes irrespective of trial enrollment

Pediatric blood & cancer, 2021-09, Vol.68 (9), p.e28315-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Potential Role of IFNγ Inhibition in Refractory Cytokine Release Syndrome Associated with CAR T-cell Therapy

Blood cancer discovery, 2022-03, Vol.3 (2), p.90

2022

Link zum Volltext

Verfügbarkeit prüfen

Cost comparison by treatment arm and center‐level variations in cost and inpatient days on the phase III high‐risk B acute lymphoblastic leukemia trial AALL0232

Cancer medicine (Malden, MA), 2018-01, Vol.7 (1), p.3-12

2018

Link zum Volltext

Verfügbarkeit prüfen

Will allogeneic CAR T cells for CD19.sup.+ malignancies take autologous CAR T cells 'off the shelf'?

Nature reviews. Clinical oncology, 2021-04, Vol.18 (4), p.195

2021

Link zum Volltext

Verfügbarkeit prüfen

Cost comparison by treatment arm and center‐level variations in cost and inpatient days on the phase III high‐risk B acute lymphoblastic leukemia trial AALL 0232

Cancer medicine (Malden, MA), 2018-01, Vol.7 (1), p.3-12

2018

Link zum Volltext

Verfügbarkeit prüfen

Complete Versus Incomplete Hematologic Recovery after CAR T Cell Therapy: Implications for Relapse Free Survival and Overall Survival in Pediatric and Young Adult Patients with Relapsed/Refractory B-ALL

Blood, 2021-11, Vol.138 (Supplement 1), p.1747-1747

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of socioeconomic status on survival after CD19 CART therapy

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.7013-7013

2022

Link zum Volltext

Verfügbarkeit prüfen

CD19-targeted chimeric antigen receptor (CAR) T cells in CNS relapsed acute lymphoblastic leukemia (ALL)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.10511-10511

2020

Link zum Volltext

Verfügbarkeit prüfen

Cytogenetic Characteristics and Outcomes of Patients Receiving CTL019 CAR T Cell Therapy

Blood, 2019-11, Vol.134 (Supplement_1), p.1464-1464

2019

Link zum Volltext

Verfügbarkeit prüfen

Trends in Inpatient and Intensive Care Resource Utilization after Chimeric Antigen Receptor T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia from 2012-2019

Blood, 2019-11, Vol.134 (Supplement_1), p.61-61

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB*
(34)
Single Journals
(27)
Journals@Ovid
(12)
Ingenta
(8)
Wiley-Blackwell Journals
(7)
IngentaConnect Journals
(5)
Wiley Online Library
(5)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(3)
Elsevier ScienceDirect Journals Complete
(3)
Nexis Uni
(2)
Nature
(2)

6 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Chimeric Antigen Receptor T‐Cell Therapy Clinical Results in Pediatric and Young Adult B‐ALL

Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States

Will allogeneic CAR T cells for CD19 + malignancies take autologous CAR T cells 'off the shelf'?

Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial

Tisagenlecleucel for treatment of children and young adults with relapsed/refractory B‐cell acute lymphoblastic leukemia

Subcutaneous immunoglobulin replacement following CD19‐specific chimeric antigen receptor T‐cell therapy for B‐cell acute lymphoblastic leukemia in pediatric patients

Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19

CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy

Analysis of semen parameters in a young cohort of cancer patients

Identifying relapses and stem cell transplants in pediatric acute lymphoblastic leukemia using administrative data: Capturing national outcomes irrespective of trial enrollment

Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill children

Potential Role of IFNγ Inhibition in Refractory Cytokine Release Syndrome Associated with CAR T-cell Therapy

Cost comparison by treatment arm and center‐level variations in cost and inpatient days on the phase III high‐risk B acute lymphoblastic leukemia trial AALL0232

Will allogeneic CAR T cells for CD19.sup.+ malignancies take autologous CAR T cells 'off the shelf'?

Cost comparison by treatment arm and center‐level variations in cost and inpatient days on the phase III high‐risk B acute lymphoblastic leukemia trial AALL 0232

Complete Versus Incomplete Hematologic Recovery after CAR T Cell Therapy: Implications for Relapse Free Survival and Overall Survival in Pediatric and Young Adult Patients with Relapsed/Refractory B-ALL

CD22-Targeted CAR-Modified T-Cells Safely Induce Remissions in Children and Young Adults with Relapsed, CD19-Negative B-ALL after Treatment with CD19-Targeted CAR T-Cells

Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Syndrome in B-Cell ALL Patients Receiving CART19

Impact of socioeconomic status on survival after CD19 CART therapy

Comprehensive Secretome Profiling Elucidates Novel Disease Biology and Identifies Pre-Infusion Candidate Biomarkers to Predict the Development of Severe Cytokine Release Syndrome in Pediatric Patients Receiving CART19

Outcomes after Reinfusion of CD19-Specific Chimeric Antigen Receptor (CAR)-Modified T Cells in Children and Young Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

CD19-targeted chimeric antigen receptor (CAR) T cells in CNS relapsed acute lymphoblastic leukemia (ALL)

Cytogenetic Characteristics and Outcomes of Patients Receiving CTL019 CAR T Cell Therapy

Trends in Inpatient and Intensive Care Resource Utilization after Chimeric Antigen Receptor T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia from 2012-2019

KMT2A Rearrangements Are Associated with Lineage Switch Following CD19 Targeting CAR T-Cell Therapy

Suchergebnisse filtern